Ascendis Pharma (Brazil) Price on September 18, 2024
| A1SN34 Stock | BRL 54.95 0.95 1.76% |
If you're considering investing in Ascendis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ascendis Pharma stands at 54.95, as last reported on the 30th of November, with the highest price reaching 54.95 and the lowest price hitting 54.95 during the day. Ascendis Pharma appears to be very steady, given 3 months investment horizon. Ascendis Pharma AS secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of standard deviation over the last 3 months. We have found twenty-two technical indicators for Ascendis Pharma AS, which you can use to evaluate the volatility of the firm. Please makes use of Ascendis Pharma's mean deviation of 1.07, and Risk Adjusted Performance of 0.0903 to double-check if our risk estimates are consistent with your expectations.
Ascendis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ascendis |
Sharpe Ratio = 0.1099
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | A1SN34 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.23 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Ascendis Pharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascendis Pharma by adding it to a well-diversified portfolio.
Ascendis Pharma Valuation on September 18, 2024
It is possible to determine the worth of Ascendis Pharma on a given historical date. On September 18, 2024 Ascendis was worth 53.35 at the beginning of the trading date compared to the closed value of 53.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ascendis Pharma stock. Still, in general, we apply an absolute valuation method to find Ascendis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ascendis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ascendis Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 52.40 | 52.40 | 52.40 | 52.40 | 35.00 | |
09/18/2024 | 53.35 | 53.35 | 53.35 | 53.35 | 64.00 |
| 53.35 | 53.35 | 53.35 | 53.35 | 1.00 |
| Backtest Ascendis Pharma | | | Ascendis Pharma History | | | Ascendis Pharma Valuation | Previous | Next |
Ascendis Pharma Trading Date Momentum on September 18, 2024
| On September 19 2024 Ascendis Pharma AS was traded for 53.35 at the closing time. The highest price during the trading period was 53.35 and the lowest recorded bid was listed for 53.35 . There was no trading activity during the period 1.0. Lack of trading volume on September 19, 2024 did not affect price variability. The overall trading delta to the current price is 1.41% . |
Ascendis Pharma AS Fundamentals Correlations and Trends
By evaluating Ascendis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ascendis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ascendis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ascendis Pharma Stock history
Ascendis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascendis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascendis Pharma AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascendis Pharma stock prices may prove useful in developing a viable investing in Ascendis Pharma
Ascendis Pharma Stock Technical Analysis
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ascendis Pharma Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Ascendis Pharma AS cannot be verified against its exchange. Please verify the symbol is currently traded on Sao Paulo Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ascendis Pharma November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascendis Pharma shares will generate the highest return on investment. By undertsting and applying Ascendis Pharma stock market strength indicators, traders can identify Ascendis Pharma AS entry and exit signals to maximize returns
Ascendis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascendis Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascendis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascendis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0903 | |||
| Jensen Alpha | 0.329 | |||
| Total Risk Alpha | (0.20) | |||
| Treynor Ratio | 7.67 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |